Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.9%

4 terminated out of 103 trials

Success Rate

89.5%

+2.9% vs benchmark

Late-Stage Pipeline

9%

9 trials in Phase 3/4

Results Transparency

24%

8 of 34 completed with results

Key Signals

8 with results89% success

Data Visualizations

Phase Distribution

70Total
Not Applicable (48)
Early P 1 (1)
P 1 (3)
P 2 (9)
P 3 (1)
P 4 (8)

Trial Status

Completed34
Recruiting30
Not Yet Recruiting11
Active Not Recruiting11
Unknown9
Terminated4

Trial Success Rate

89.5%

Benchmark: 86.5%

Based on 34 completed trials

Clinical Trials (103)

Showing 20 of 20 trials
NCT05109468Active Not Recruiting

Assessment of Patients' Quality of Sexual Life After Anal Cancer Treatment

NCT07730801Not ApplicableNot Yet Recruiting

National Rapid TLC: Testing and Linkage to Care

NCT07281599Not ApplicableRecruiting

Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer

NCT07498075Not ApplicableRecruitingPrimary

Digital Interventions to Increase HPV Vaccination Intentions Among Nigerian Caregivers

NCT04722822Not ApplicableCompletedPrimary

The HPV 9-10 Trial: Early Initiation of HPV Vaccination

NCT06979180Not ApplicableRecruiting

A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.

NCT01011712Recruiting

The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise

NCT04965792Active Not RecruitingPrimary

Post-treatment Surveillance in HPV+ Oropharyngeal SCC

NCT07645352Not ApplicableNot Yet Recruiting

Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 Zimbabwe

NCT04708470Phase 1Active Not Recruiting

A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers

NCT07645378Not ApplicableNot Yet Recruiting

Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South Africa

NCT07632963Not ApplicableNot Yet RecruitingPrimary

Addressing HPV Vaccine Hesitancy by Co-Designing a Digital Health Intervention

NCT07620795Not ApplicableNot Yet Recruiting

Effect of Web-Based Education on Attitudes and Beliefs About HPV Testing

NCT06380114Not ApplicableRecruitingPrimary

Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination

NCT05984849Not ApplicableRecruitingPrimary

Playing Game to Learn About Children's Vaccine Project

NCT06144229Enrolling By Invitation

Real-world Effectiveness of HPV Vaccine in Women Living With HIV and Its Impact on Cervical Cancer Screening Accuracies

NCT06588257Phase 4CompletedPrimary

Acceptability of the HPV Vaccine and Anal HPV in Transgender Women and Men Who Have Sex With Men: A Pilot Study

NCT05363709Phase 2WithdrawnPrimary

BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients

NCT07345897Not ApplicableRecruitingPrimary

Emergency Department-based Cervical Cancer Screening Through Self-sampling

NCT07562984Not ApplicableNot Yet RecruitingPrimary

A Bio-Psycho-Social Medical Model-Based Study on Adolescent Female HPV Vaccination Behavior and Comprehensive Intervention

Scroll to load more

Research Network

Activity Timeline